Feasability of a new process to produce fast disintegrating pellets as novel multiparticulate dosage form for

Thanh Huong Hoang Thi1, Siham Lhafidi1, Simone Pinto Carneiro2

  • 1Univ. Lille, Inserm, CHU Lille, U 1008-Controlled Drug Delivery Systems and Biomaterials, F-5900 Lille, France.

Insights

A novel orally disintegrating system using microcrystalline cellulose-based pellets was developed for pediatric patients. This system ensures rapid disintegration and fast drug release, overcoming challenges with pediatric dosage forms.

Area of Science:

  • Pharmaceutical Technology
  • Drug Delivery Systems
  • Pediatric Formulations

Background:

  • Pediatric patients often struggle with swallowing solid dosage forms like tablets and capsules.
  • Developing age-appropriate and flexible-dosed medications for children presents significant formulation challenges.

Purpose of the Study:

  • To develop a novel orally disintegrating multiparticulate system for pediatric use.
  • To create an alternative dosage form addressing swallowing difficulties and dose variability in children.

Main Methods:

  • Acetaminophen-loaded microcrystalline cellulose pellets were prepared using extrusion/spheronization and freeze-drying.
  • Pellet characteristics (size, sphericity, friability, drug release) were evaluated.
  • In vitro disintegration and internal porous structure (mercury intrusion, gas adsorption, SEM) were analyzed.

Main Results:

  • High drug loading (up to 75% w/w) pellets with good sphericity and low friability were produced.
  • Pellets demonstrated instantaneous disintegration (<5s) due to a porous internal structure.
  • Over 90% acetaminophen release was achieved within 15 minutes.

Conclusions:

  • The developed orally disintegrating multiparticulate system offers an age-appropriate and easily administrable dosage form for pediatric populations.
  • This novel system provides dosing flexibility and overcomes common administration issues in children.
  • The freeze-dried pellets exhibit favorable mechanical properties alongside rapid disintegration and dissolution.

Related Concept Videos

Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules01:18

Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules

Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
403
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
216
Factors Affecting Dissolution: Particle Size and Effective Surface Area01:23

Factors Affecting Dissolution: Particle Size and Effective Surface Area

Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
2.0K
Factors Influencing Drug Absorption: Pharmaceutical Parameters01:28

Factors Influencing Drug Absorption: Pharmaceutical Parameters

Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
764
Modified-Release Drug Delivery Systems: Rate-Programmed I01:22

Modified-Release Drug Delivery Systems: Rate-Programmed I

Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
103
Oral Drug Delivery Systems: Introduction01:23

Oral Drug Delivery Systems: Introduction

Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
211